José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
Treatment with baclofen via intrathecal — spinal canal — infusion is superior to placebo in the achievement of individual treatment goals in children, adolescents, and young adults with severe ... Read more
The largest worldwide population-based study — including all European and Australian regions — hopes to determine the frequency of specific congenital anomalies in cerebral palsy patients, as well as cerebral palsy risk ... Read more
Injections of botulinum toxin type A (BoNT-A) cause more frequent systemic adverse events in children with severe cerebral palsy than in those who have milder disease. That finding may warrant ... Read more
Low family income and living in rural areas are associated with higher prevalence of cerebral palsy, a study from Taiwan shows. The research, “Association between socioeconomic status and cerebral ... Read more
Rhythmic auditory entrainment — a process that provides a timing cue for a biological rhythm — improves gait performance in patients with cerebral palsy (CP), research from Germany suggests. The study, ... Read more
Botulinum toxin A (BoNT-A) does not appear to improve spasticity in cerebral palsy (CP) in children treated with intensive physiotherapy, a Dutch study shows. The research, “Value of botulinum ... Read more
Intrathecal injection of baclofen (ITB) improves dystonia, muscle tone, pain, and other impairments in patients with dyskinetic cerebral palsy (CP), a new study from Sweden shows. The study, “Intrathecal baclofen ... Read more